DrugDashboards

Cepacol Extra Strength Sore Throat and Cough

BENZOCAINE and DEXTROMETHORPHAN HYDROBROMIDE · DEXTROMETHORPHAN HYDROBROMIDE 5 mg/1; BENZOCAINE 7.5 mg/1 · Lozenge · Oral · Reckitt Benckiser LLC

NDC 63824-0744-16 · 2 BLISTER PACK in 1 CARTON / 8 LOZENGE in 1 BLISTER PACK · OTC MONOGRAPH DRUG · View full market →

The short version

Only one company currently supplies this market — there is no backup if it stumbles. The price has held steady around $0.1509 per unit over the past year.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

Medicare Part D does not cover over-the-counter drugs — by law it pays only for products requiring a prescription.

How Part D pricing works →

NADAC price per unit

$0$0.1$0.2May 2020Jun 2024$0.1509
13 price points · per · last surveyed Invalid DateSource: CMS NADAC

Medicaid spend (2024)

$1,772
225 prescriptions paid by Medicaid nationally · all Medicaid spend →

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

Regulatory

Application
M012
TE code
Approval date
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of BENZOCAINE and DEXTROMETHORPHAN HYDROBROMIDE (Lozenge)

LabelerStrengthFirst seenLast seen
Reckitt Benckiser LLCDEXTROMETHORPHAN HYDROBROMIDE 5 mg/1; BENZOCAINE 7.5 mg/1Aug 26, 2026Sep 2, 2026
Reckitt Benckiser LLCDEXTROMETHORPHAN HYDROBROMIDE 7.5 mg/1; BENZOCAINE 5 mg/1Jul 22, 2026Aug 19, 2026
Reckitt Benckiser LLCBENZOCAINE 7.5 mg/1; DEXTROMETHORPHAN HYDROBROMIDE 5 mg/1Jul 15, 2026Jul 15, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Cepacol Extra Strength Sore Throat and Cough — NDC 63824-0744-16," retrieved September 3, 2026, https://drugdashboards.com/drug/63824074416.

Free to cite with attribution — see how the data is put together.